Oncology Vol 29 No 4_Suppl_1

(P005) Ultrasensitive PSA Identifies Patients With Organ-Confined Prostate Cancer Requiring Postop Radiotherapy

(P001) Disparities in the Local Management of Breast Cancer in the United States According to Health Insurance Status

(P002) Predictors of CNS Disease in Metastatic Melanoma: Desmoplastic Subtype Associated With Higher Risk

(P003) Identification of Somatic Mutations Using Fine Needle Aspiration: Correlation With Clinical Outcomes in Patients With Locally Advanced Pancreatic Cancer

(P004) A Retrospective Study to Assess Disparities in the Utilization of Intensity-Modulated Radiotherapy (IMRT) and Proton Therapy (PT) in the Treatment of Prostate Cancer (PCa)

(S001) Tumor Control and Toxicity Outcomes for Head and Neck Cancer Patients Re-Treated With Intensity-Modulated Radiation Therapy (IMRT)-A Fifteen-Year Experience

(S003) Weekly IGRT Volumetric Response Analysis as a Predictive Tool for Locoregional Control in Head and Neck Cancer Radiotherapy 

(S004) Combination of Radiotherapy and Cetuximab for Aggressive, High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: A Propensity Score Analysis

(S005) Radiotherapy for Carcinoma of the Hypopharynx Over Five Decades: Experience at a Single Institution

(S002) Prognostic Value of Intraradiation Treatment FDG-PET Parameters in Locally Advanced Oropharyngeal Cancer

(P006) The Role of Sequential Imaging in Cervical Cancer Management

(P008) Pretreatment FDG Uptake of Nontarget Lung Tissue Correlates With Symptomatic Pneumonitis Following Stereotactic Ablative Radiotherapy (SABR)

(P009) Monte Carlo Dosimetry Evaluation of Lung Stereotactic Body Radiosurgery

(P010) Stereotactic Body Radiotherapy for Treatment of Adrenal Gland Metastasis: Toxicity, Outcomes, and Patterns of Failure

(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis

(P012) Characteristics of Mentorship During Radiation Oncology Residency

(P013) Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-Based Study Evaluating Healthcare Disparities in the United States According to Insurance Status

(P015) Radiation Biological Responses of MRI-Linac vs Linac in Human Head and Neck and Lung Cancer Cells

(P016) The Cell Cycle Inhibitor P21 Regulates Langerhans Cell Radiation Resistance and PromotesT Regulatory Cell Induction Upon Exposure to Radiotherapy

(P017) Dosimetric Evaluation of Respiratory-Gated Radiotherapy for Left-Sided Breast Cancer

(P018) Accelerated Partial Breast Radiotherapy Using VMAT-A Preliminary Dosimetric Comparison to Single-Entry Brachytherapy

(P020) 3D Conformal External Beam Radiation Therapy May Result in Lower Heart Dose and Risk of Radiation-Induced Major Coronary Events Compared With Multicatheter Balloon High-Dose-Rate Brachytherapy for Left-Sided Breast Cancer Patients

(P021) Improving Clinical Documentation and Prospectively Populating a Research Database Through an Electronic Data Capture System for Routine Clinical Care

(P022) Proton Therapy on an Incline Beam Line: Acute Toxicity Outcomes in Locally Advanced Breast Cancer Patients

(P019) Predictors of Outcomes in Breast Cancer Patients With Oligometastases

(S015) Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States

(S013) Heterogeneity Within the Prostate and Risk-Adapting Dose-Volume Analysis With SBRT for Prostate Cancer

(S012) Trends in the Selection of Definitive Treatment for Newly Diagnosed Prostate Cancer in Men < 60 Years Old

(S011) Hypofractionated vs Standard Fractionated Proton Beam Therapy for Early-Stage Prostate Cancer: Interim Results of a Randomized Prospective Trial

(S010) A Phase III Randomized Trial of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial-Feasibility and Acute Toxicity